Topics and Expertise: clinical trials

Oni-Orisan was recognized for his contributions to clinical pharmacology.

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

The photograph of Martin Luther King Jr. hanging on the wall of the Asthma Collaboratory lab in UC San Francisco’s Rock Hall serves a reminder to all who toil there, purifying DNA samples or analyzing genetic, social or environmental data that their research is also part of a dream of equality and...

Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most...

The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.

Every year U.S. drug regulators approve dozens of new medicines as “safe and effective,” but just how effective are they? How well do they alleviate specific aspects of illness, whether light sensitivity from migraine headaches or itching from eczema?

Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and...

Published results of drug trials sponsored by the pharmaceutical industry are more likely than trials not sponsored by the industry to favor drug over placebo, according to